Transarterial Chemoembolization

Transarterial Chemoembolization for the Treatment of Uveal Melanoma With Liver Metastases

Cabozantinib Combined With Ipilimumab/Nivolumab and TACE in Patients With Hepatocellular Carcinoma

Phase II Trial of Lung Chemoemobolization

Contrast Enhanced Ultrasound to Evaluate Response to Chemoembolization in Patients With Liver Tumors

Clinical Efficacy of Transarterial Chemoembolization in Elderly Patients With Advanced Unresectable Colorectal Cancer

Partial Immune-boost TACE in unrEseCTable HCC Patients Under Systemic Treatment

A Study of Participants With Initially Unresectable Hepatocellular Carcinoma That is Treated With Atezolizumab and Bevacizumab Plus Transarterial Chemoembolization

Transarterial Chemoembolization (TACE) Versus TACE Plus Stereotactic Body Radiation Therapy (SBRT) in Liver Carcinoma

Study of Pembrolizumab Following TACE in Primary Liver Carcinoma

Atezolizumab and Bevacizumab in Combination With TACE for Patients With BCLC B HCC

Randomized Embolization Trial for NeuroEndocrine Tumor Metastases to the Liver

HAIC Plus Sorafenib Versus TACE Plus Sorafenibfor Advanced HCC

Transarterial Chemoembolization Versus Proton Beam Radiotherapy for the Treatment of Hepatocellular Carcinoma

Transarterial Chemoembolization Compared With Stereotactic Body Radiation Therapy or Stereotactic Ablative Radiation Therapy in Treating Patients With Residual or Recurrent Liver Cancer Undergone Initial Transarterial Chemoembolization

Survival Analysis: TACE vs. Combination Therapy in HCC

HAIC Versus TACE for Large Hepatocellular Carcinoma Staged BCLC A/B.

Adjuvant Radiotherapy Comparing TACE for Curative HCC

Transarterial Chemoembolization With Lipiodol in the Treatment of Initial Unresectable Gastric Cancer (GC)

Safety of Transarterial Chemoembolization (TACE) in the Setting of an Elevated Bilirubin

Chemoembolization of the Liver With or Without Sunitinib Malate in Treating Patients With Liver Cancer